Sponsor hub
Emory University clinical trial failures
Review 99 stopped clinical trials from Emory University, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 6 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 59
- OTHER/UNKNOWN
- 34
- SAFETY
- 4
- EFFICACY/FUTILITY
- 2
Notable sponsors
- Emory University
- 99
Related phases
- Phase II
- 39
- Phase IV
- 22
- Phase I
- 17
- Phase III
- 9
- Unknown
- 8
Crawlable stopped-trial records
Open ExploreShowing up to 99 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Early Phase I Gliosarcoma trial by Emory University. Stop reason: OPERATIONAL.
Review of Drug Supply
Phase II Injection Site Irritation trial by Emory University. Stop reason: OPERATIONAL.
Study was terminated due to enrollment challenges following the relocation of orthopedic procedures to a different hospital.
Phase II Recurrent Hepatocellular Carcinoma trial by Emory University. Stop reason: OPERATIONAL.
Slow Accrual
Phase I Clinical Stage IV Cutaneous Melanoma AJCC v8 trial by Emory University. Stop reason: OPERATIONAL.
Slow accrual
Phase II Oropharynx Cancer, Stage I trial by Emory University. Stop reason: OTHER/UNKNOWN.
Institutional Review
Phase II Sickle Cell Anemia in Children trial by Emory University. Stop reason: OPERATIONAL.
This study was terminated on September 26, 2024 due to voluntary withdrawal of study drug from the market.
Phase IV Appendicitis trial by Emory University. Stop reason: OPERATIONAL.
Study was terminated due to lack of funding.
Phase II Metastatic Prostate Adenocarcinoma trial by Emory University. Stop reason: OPERATIONAL.
Per sponsor memo screening and enrollment of new patients for all ongoing Regeneron sponsored studies with vidutolimod are being paused until further notice
Phase I Castration-Sensitive Prostate Carcinoma trial by Emory University. Stop reason: OTHER/UNKNOWN.
To review the safety data.
Phase III COVID-19 trial by Emory University. Stop reason: OPERATIONAL.
Study was terminated due to lack of funding.
Phase IV Trachoma trial by Emory University. Stop reason: OTHER/UNKNOWN.
The Trachoma Elimination Study by Focused Antibiotic (TESFA): The Impact of an Enhanced Antibiotic Treatment Regimen on Trachoma in Amhara, Ethiopia is withdrawn due to severe delays and continued insecurity in the Amhara region of Ethiopia.
Phase I Asthma trial by Emory University. Stop reason: OPERATIONAL.
The study terminated due to funding ending.
Phase III Allergic Fungal Rhinosinusitis trial by Emory University. Stop reason: OPERATIONAL.
The study was terminated due to funding ending.
Phase II Cytokines trial by Emory University. Stop reason: OPERATIONAL.
Accrual goal met
Phase IV Congenital Heart Disease trial by Emory University. Stop reason: OPERATIONAL.
The study activities were suspended due to COVID-19, and the interim analysis did not yield positive results once resumed.
Phase II Non-small Cell Lung Cancer trial by Emory University. Stop reason: EFFICACY/FUTILITY.
This study was terminated after interim analyses showed no benefits.
Phase IV Hyperglycemia Stress trial by Emory University. Stop reason: OTHER/UNKNOWN.
This clinical trial was terminated on June 7, 2024 due to new information about contraindications of using the study drug in this population.
Phase I Lung Non-Small Cell Carcinoma trial by Emory University. Stop reason: OPERATIONAL.
Accrual goal not met.
Phase I Mycosis Fungoides trial by Emory University. Stop reason: OPERATIONAL.
Lack of funding
Phase II Plasma Cell Myeloma trial by Emory University. Stop reason: OPERATIONAL.
slow accrual
Phase II Plasma Cell Myeloma trial by Emory University. Stop reason: OPERATIONAL.
Slow accrual
Phase IV Stress Hyperglycemia trial by Emory University. Stop reason: SAFETY.
The study was terminated following the Data and Safety Monitoring Board (DSMB) review due to concerns with perioperative use of the study drug.
Phase III Hemophilia A trial by Emory University. Stop reason: OPERATIONAL.
The Emi PUPs and Nuwiq ITI study has been closed due to slow enrollment and study site startup.
Phase II Resectable Intrahepatic Cholangiocarcinoma trial by Emory University. Stop reason: OTHER/UNKNOWN.
PI has decided to terminate this study due to study supporter pulling support on this study.
Phase I Infection Due to Resistant Organism trial by Emory University. Stop reason: OPERATIONAL.
This study was paused and was not resumed due to the COVID-19 pandemic.
Phase IV Depression trial by Emory University. Stop reason: OPERATIONAL.
The study was suspended in March 2020 due to the COVID-19 pandemic and ultimately was terminated as it is not safe to test a potent anti-inflammatory drug with ongoing surges of COVID-19.
Phase IV Anesthesia trial by Emory University. Stop reason: OTHER/UNKNOWN.
Loss of surgery team member deemed the study procedures impossible to achieve, and no replacement could be found in a timely manner to complete trial as initially planned.
Phase II Alcoholism trial by Emory University. Stop reason: OPERATIONAL.
Study was suspended in 2020 due to COVID-19 pandemic as a result of recruitment challenges and the inability to conduct all study procedures (e.g., bronchoscopy) per protocol. In late 2021 the decision was made to not re-open the study.
Phase IV HIV trial by Emory University. Stop reason: OPERATIONAL.
This study terminated early due to the ongoing covid-19 pandemic making it unsafe to recruit participants for in-person visits. Participants are living with HIV who are antiretroviral therapy-naive and are at high risk of COVID-19 complications.
Early Phase I Recurrent Glioblastoma trial by Emory University. Stop reason: OPERATIONAL.
Per the PI-slow accrual
Phase II Differentiated Thyroid Gland Carcinoma trial by Emory University. Stop reason: OPERATIONAL.
Study has been abandoned for lack of accrual
Phase IV Tenosynovitis trial by Emory University. Stop reason: OPERATIONAL.
Enrollment and study activities were initially suspended due to COVID-19. The investigator has also left Emory and the study will not resume.
Phase II Prostate Cancer trial by Emory University. Stop reason: OPERATIONAL.
Enrollment and study activities were suspended due to COVID-19.
Phase II Hematological Malignancies trial by Emory University. Stop reason: OPERATIONAL.
Slow accrual
Phase IV Influenza trial by Emory University. Stop reason: OPERATIONAL.
The study closed prior to completing year 3 of the study due to the COVID-19 pandemic.
Phase II Acute Myeloid Leukemia trial by Emory University. Stop reason: OTHER/UNKNOWN.
Due to unforeseen circumstances, the study team was limited in enrolling patients on this trial; thus, it was terminated.
Phase II Critical Illness trial by Emory University. Stop reason: OPERATIONAL.
This study was halted pending additional funding and ultimately was terminated due to difficulties with ongoing recruitment, etc.
Phase II Estrogen Receptor-positive Breast Cancer trial by Emory University. Stop reason: OPERATIONAL.
Slow to accrual
Phase II Lung Non-Small Cell Carcinoma trial by Emory University. Stop reason: OPERATIONAL.
Due to accrual issues
Phase I Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8 trial by Emory University. Stop reason: OPERATIONAL.
Closed due to low (0) accrual
Phase IV Covid19 trial by Emory University. Stop reason: OPERATIONAL.
Study stopped due to issues with enrollment and lack of funding.
Phase IV Otolaryngeal Cancer trial by Emory University. Stop reason: OPERATIONAL.
Halted due to COVID 19; we believe we have adequate data for analysis
Phase I HIV/AIDS trial by Emory University. Stop reason: OPERATIONAL.
Study terminated early due to lack of funding and the COVID-19 pandemic.
Phase II Ulcerative Colitis trial by Emory University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase III Pain, Postoperative trial by Emory University. Stop reason: OPERATIONAL.
Study initially suspended recruitment due to COVID-19. Study withdrawn due to PI leaving institution in early 2021.
Phase II Non-Alcoholic Fatty Liver Disease trial by Emory University. Stop reason: SAFETY.
Terminated due to lack of efficacy and safety concerns.
Phase II Diabetic Macular Edema trial by Emory University. Stop reason: OPERATIONAL.
The study team was unable to secure sufficient funding and administrative support.
Phase III Cerebrovascular Accident trial by Emory University. Stop reason: OTHER/UNKNOWN.
Study abandoned due to drug billing issues
Phase III Stage I Gallbladder Cancer AJCC v8 trial by Emory University. Stop reason: OTHER/UNKNOWN.
This trial will open as an NCTN trial.
Phase II Menopausal Osteoporosis trial by Emory University. Stop reason: OTHER/UNKNOWN.
Investigator terminated trial pursuant to research contract rights.
Phase II Acute Myelogenous Leukemia (AML) trial by Emory University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase I Recurrent Chronic Lymphocytic Leukemia trial by Emory University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase I Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma trial by Emory University. Stop reason: OPERATIONAL.
funding and drug were withdrawn
Early Phase I Snoring trial by Emory University. Stop reason: OTHER/UNKNOWN.
PI is moving the a new institution and ended the study early.
Phase IV Red Blood Cell Transfusion trial by Emory University. Stop reason: OPERATIONAL.
Difficulties in recruiting.
Phase II Recurrent Non-Small Cell Lung Carcinoma trial by Emory University. Stop reason: OPERATIONAL.
Slow accrual
Phase IV Cystic Fibrosis Related Bone Disease trial by Emory University. Stop reason: OPERATIONAL.
Issues with Recruitment.
Phase II Tardive Dyskinesia trial by Emory University. Stop reason: OTHER/UNKNOWN.
No participants
Phase II Chronic Myelogenous Leukemia, BCR-ABL1 Positive trial by Emory University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase I Sickle Cell Disease trial by Emory University. Stop reason: OTHER/UNKNOWN.
Study stopped due to a competing trial.
Phase II Chronic Myelogenous Leukemia trial by Emory University. Stop reason: OPERATIONAL.
Original principal investigator left institution
Phase IV Atherosclerosis trial by Emory University. Stop reason: OTHER/UNKNOWN.
The study was stopped when the original principal investigator moved to a new institution.
Phase II Hyperlipidemia trial by Emory University. Stop reason: OTHER/UNKNOWN.
Limited clinical staff
Phase I Diabetes Insipidus trial by Emory University. Stop reason: OTHER/UNKNOWN.
Lack of effect in initial subjects
Phase III Cystic Fibrosis trial by Emory University. Stop reason: OPERATIONAL.
Could not achieve target enrollment
Phase II Heart Valve Disease trial by Emory University. Stop reason: OPERATIONAL.
Insufficient funding to complete total projected enrollment
Phase II Acute Leukemia trial by Emory University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase IV Recurrent Tonsillitis trial by Emory University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase I Acute Myeloid Leukemia trial by Emory University. Stop reason: OTHER/UNKNOWN.
Withdrawn due to lack of participants.
Early Phase I Cancers of the Head and Neck trial by Emory University. Stop reason: OTHER/UNKNOWN.
Change in Principal Investigator and protocol revisions delayed study start and ultimately the decision was made to cancel the study.
Phase IV Sexual Dysfunction, Physiological trial by Emory University. Stop reason: OPERATIONAL.
Obstacles with recruitment
Unknown HIV trial by Emory University. Stop reason: OTHER/UNKNOWN.
Minimal efficacy of maraviroc alone was found in preliminary data analysis of another study.
Unknown Major Depressive Disorder trial by Emory University. Stop reason: OPERATIONAL.
Lack of success with recruitment
Unknown Congenital Disorders trial by Emory University. Stop reason: OPERATIONAL.
Lack of enrollment
Phase II Multiple Myeloma trial by Emory University. Stop reason: OPERATIONAL.
Logistical reasons
Phase II Liver Cancer trial by Emory University. Stop reason: SAFETY.
safety issue observed on another hepatocellular study using OSI906
Phase II Squamous Cell Carcinoma trial by Emory University. Stop reason: SAFETY.
Safety reasons
Phase III Epilepsy, Partial trial by Emory University. Stop reason: OPERATIONAL.
Poor recruitment
Unknown Hematologic Malignancies trial by Emory University. Stop reason: OPERATIONAL.
lack of enrollment
Phase II Breast Neoplasms trial by Emory University. Stop reason: OPERATIONAL.
Funding withdrawn
Unknown Thalassemia trial by Emory University. Stop reason: OTHER/UNKNOWN.
drug company is no longer making the drug
Phase III Lung Injury, Acute (ALI) trial by Emory University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase IV Type 1 Diabetes trial by Emory University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase IV Complications trial by Emory University. Stop reason: OTHER/UNKNOWN.
The study was withdrawn prior to IRB approval.
Unknown Lumbar Spinal Stenosis trial by Emory University. Stop reason: OPERATIONAL.
Lack of recruitment
Phase II Estrogen Receptor-positive Breast Cancer trial by Emory University. Stop reason: OPERATIONAL.
Slow accrual
Phase I Leukemia trial by Emory University. Stop reason: OPERATIONAL.
Slow accrual
Unknown Meniere Disease trial by Emory University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase IV Heart Defect, Congenital trial by Emory University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Breast Cancer trial by Emory University. Stop reason: OPERATIONAL.
Slow accrual, availability of other clinical options
Phase II Breast Neoplasms trial by Emory University. Stop reason: OPERATIONAL.
Slow accrual
Phase II Pancreatic Neoplasms trial by Emory University. Stop reason: OPERATIONAL.
Slow accrual
Phase I Stage I Hypopharyngeal Squamous Cell Carcinoma trial by Emory University. Stop reason: OPERATIONAL.
Lack of funding
Phase II Hepatocellular Cancer trial by Emory University. Stop reason: EFFICACY/FUTILITY.
Primary endpoint not met
Phase I Pancreatic Neoplasms trial by Emory University. Stop reason: OTHER/UNKNOWN.
PI moved to different institution
Unknown Guillain-Barre Syndrome trial by Emory University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase IV Congestive Heart Failure trial by Emory University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase I Breast Cancer trial by Emory University. Stop reason: OPERATIONAL.
Slow accrual
Phase IV Hyperparathyroidism, Secondary trial by Emory University. Stop reason: OPERATIONAL.
slow enrollment and discontinued once original principal investigator left Emory